NASDAQ$OMCL
Omnicell Inc. · Q1 2026 earnings
Q1 2026 earnings · · Before market open · Investor relations
Briefing
Omnicell reported Q1 2026 with $309.9M revenue, net income of $11.4M, and diluted EPS of $0.22.
For the period ended 2026-03-31, Omnicell reported $309.9M revenue. Total revenues $309.9M pharmacy automation. Net income $11.4M vs prior loss. Installed base and SaaS. Hospital capex and ARR growth.
- Total revenues $309.9M pharmacy automation.
- Net income $11.4M vs prior loss.
- Installed base and SaaS.
Headline financials
Revenue & EPS history
Omnicell · Revenue · Quarterly
$310M
Revenue by segment
Omnicell · $188M total across 1 segment · Q2 2023
- Product revenues$188M-19.4%100.0%
Forward guidance
Hospital capex and ARR growth.
Tailwinds
- Return to profit.
- Automation adoption.
- Recurring software.
Headwinds
- Hospital capex cycles.
- Competition.
- Implementation timing.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2026
+0.7%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+4.7%
Avg return
30 days after
55%
36 / 65 earnings
Positive
+34.3%
Q2 2024
Best reaction
-29.4%
Q3 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | +13.7% | +18.8% | |
| Q4 2025 | -16.3% | -16.5% | -11.5% | |
| Q3 2025 | +13.4% | +16.7% | +23.5% | |
| Q1 2025 | -16.0% | -15.4% | +1.2% | |
| Q4 2024 | -11.2% | -7.1% | -16.7% | |
| Q3 2024 | +21.2% | +20.9% | +16.1% | |
| Q2 2024 | +34.3% | +41.6% | +52.3% | |
| Q1 2024 | +10.9% | +11.5% | +19.9% | |
| Q4 2023 | -15.6% | -11.9% | -12.0% | |
| Q3 2023 | -14.9% | -13.9% | -5.5% | |
| Q2 2023 | +2.3% | +2.9% | -10.0% | |
| Q1 2023 | +8.9% | +7.1% | +18.6% | |
| Q4 2022 | +7.9% | +6.6% | +6.4% | |
| Q3 2022 | -29.4% | -35.9% | -33.4% | |
| Q2 2022 | -2.1% | -5.6% | -10.6% | |
| Q1 2022 | +1.2% | +5.9% | +4.7% | |
| Q4 2021 | -9.6% | -18.4% | -11.5% | |
| Q3 2021 | +2.2% | +1.6% | +1.5% | |
| Q2 2021 | -1.1% | +0.4% | +7.1% | |
| Q1 2021 | +1.8% | -1.5% | -2.4% | |
| Q4 2020 | +7.0% | +8.9% | +6.5% | |
| Q3 2020 | +2.3% | +2.9% | +27.0% | |
| Q2 2020 | +9.1% | +5.5% | +2.7% | |
| Q1 2020 | -6.1% | -12.3% | -0.5% | |
| Q4 2019 | -1.4% | +2.3% | -4.5% | |
| Q3 2019 | -3.7% | -1.9% | +7.4% | |
| Q2 2019 | +6.7% | +5.4% | +0.6% | |
| Q1 2019 | +0.7% | +3.8% | +4.7% | |
| Q4 2018 | +17.9% | +21.0% | +28.0% | |
| Q3 2018 | +6.1% | +15.2% | +18.8% | |
| Q2 2018 | +13.7% | +13.0% | +29.5% | |
| Q1 2018 | +1.6% | -0.1% | +5.3% | |
| Q4 2017 | -6.2% | -9.8% | -12.9% | |
| Q3 2017 | -6.4% | -8.2% | -7.6% | |
| Q2 2017 | +12.5% | +16.3% | +12.1% | |
| Q1 2017 | -3.2% | -1.7% | +0.0% | |
| Q4 2016 | -0.7% | +1.0% | +4.5% | |
| Q3 2016 | -6.3% | -6.8% | +3.2% | |
| Q2 2016 | +6.8% | +4.7% | +3.4% | |
| Q1 2016 | +3.9% | — | — | |
| Q4 2015 | -1.0% | — | — | |
| Q3 2015 | -10.5% | — | — | |
| Q2 2015 | -8.8% | — | — | |
| Q1 2015 | -2.6% | — | — | |
| Q4 2014 | +5.3% | — | — | |
| Q3 2014 | +9.7% | — | — | |
| Q2 2014 | -3.9% | — | — | |
| Q1 2014 | +0.4% | — | — | |
| Q4 2013 | +8.9% | — | — | |
| Q3 2013 | -1.4% | — | — | |
| Q2 2013 | +8.7% | — | — | |
| Q1 2013 | +7.6% | — | — | |
| Q3 2010 | -1.3% | — | — | |
| Q4 2012 | +13.4% | — | — | |
| Q3 2012 | +12.2% | — | — | |
| Q2 2012 | +0.9% | — | — | |
| Q1 2011 | -0.3% | — | — | |
| Q1 2012 | +4.8% | — | — | |
| Q4 2011 | +2.6% | — | — | |
| Q4 2009 | +2.6% | — | — | |
| Q3 2011 | -0.7% | — | — | |
| Q2 2010 | -16.9% | — | — | |
| Q2 2011 | -16.9% | — | — | |
| Q4 2010 | -16.9% | — | — | |
| Q1 2010 | +7.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro